Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Molecular Therapy

Topics

Biology

Epidemiology

Immunology

Genetics

Haematopoiesis

Show all topics

DOI

10.1038/mt.2013.151

License

CC-BY-NC-ND

Other Formats

PDF